| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/05/2013 | CN103127063A Application of chloranthus japonicus alcohol F in preparation of antitumor drugs |
| 06/05/2013 | CN103127062A Application of 13'-acetyl silver grass alcohol C in manufacturing of antineoplastic drugs |
| 06/05/2013 | CN103127061A Medicine application of chloranthus japonicus alcohol M |
| 06/05/2013 | CN103127060A Application of chloranthus japonicus alcohol D in preparation of antitumor drugs |
| 06/05/2013 | CN103127057A Application of fraxinellone in preparing of antineoplastic medicines |
| 06/05/2013 | CN103127056A Application of psoromic acid in anti-tumor drug preparation |
| 06/05/2013 | CN103127055A Application of tangeretin serving as sensitizer used for preparing chemotherapeutics used for curing solid tumor |
| 06/05/2013 | CN103127054A Applications of dihydro chromone framework compounds in preparing medicine for curing malignant tumor |
| 06/05/2013 | CN103127052A Treatment composition and relevant application method |
| 06/05/2013 | CN103127051A Application of curcumenol in anti-tumor drug preparation |
| 06/05/2013 | CN103127049A Application of usnic acid in manufacturing antitumor drugs |
| 06/05/2013 | CN103127045A Composition containing gamma-aminobutyric acid and lycopene and preparation method thereof |
| 06/05/2013 | CN103127039A Application of magnolol in preparation of antitumor drug |
| 06/05/2013 | CN103127027A Polysaccharide sulphate dropping pill |
| 06/05/2013 | CN103127013A Polysaccharide sulphate lipidosome tablet |
| 06/05/2013 | CN103127007A Sodium glycididazole composition and preparation method thereof |
| 06/05/2013 | CN103126999A Thymalfasin chitosan / beta-cyclodextrin composite microsphere drug delivery system and preparation method |
| 06/05/2013 | CN103126993A Tumor cell active targeting drug delivery system based on nanometer particles and construction method thereof |
| 06/05/2013 | CN103126979A Luteolin solution composition |
| 06/05/2013 | CN103126973A Sugar water gel liquid emboliaztion agent for hemangioma cure and preparation method thereof |
| 06/05/2013 | CN103125946A Lutein nanoparticle and its preparation method |
| 06/05/2013 | CN102746309B 1-N-ethyl-4-N-2'-substituted acylhydrazine-1H-pyrazol [3, 4-d] miazines derivative as well as preparation method and application thereof |
| 06/05/2013 | CN102703452B siRNA double-strand for inhibiting Bcl2 gene expression and application thereof |
| 06/05/2013 | CN102634432B Desert cistanche and black rice health maintenance wine and production method thereof |
| 06/05/2013 | CN102600077B Gemcitabine or gemcitabine salt nano-emulsion injecta and preparation method thereof |
| 06/05/2013 | CN102579738B Internal traditional Chinese medicine capsule for treating uterine tumor |
| 06/05/2013 | CN102579454B Drug composition for curing tumour diseases |
| 06/05/2013 | CN102552757B Jiakeshexing decoction for chronic lymphocytic leukemia |
| 06/05/2013 | CN102552309B Application and preparation method of gold hyaluronic acid |
| 06/05/2013 | CN102552147B Bullatacin ethosome gel and preparation method thereof |
| 06/05/2013 | CN102533996B Method for determining APRIL (A Proliferation-inducing Ligand) gene promoter and transcription factor binding site and use |
| 06/05/2013 | CN102525954B Lyophilized emulsion preparation for injection of levo-gossypol and acetate of levo-gossypol |
| 06/05/2013 | CN102485217B Letrozole tablet with high dissolubility and preparation method thereof |
| 06/05/2013 | CN102416001B Octreotide acetate freeze-dried powder injection for injection and preparation method thereof |
| 06/05/2013 | CN102372773B Human bladder cancer tumor marker, antibody thereof and application thereof |
| 06/05/2013 | CN102357123B Application of herba dicranostigmae alcohol extract in preparing medicines for resisting melanoma transfer |
| 06/05/2013 | CN102342946B Application of bile acid peiminine ester and its derivative in preparation of antitumor medicines |
| 06/05/2013 | CN102309764B Method for aiding polyethylene glycol (PEG) to modify protein medicament by using organic solvent |
| 06/05/2013 | CN102304091B Emodin and fluorouracil combined compound having antitumor activity and preparation method thereof |
| 06/05/2013 | CN102295708B Optimization method for processing technology of active polysaccharide product |
| 06/05/2013 | CN102294025B Compound of prostate stem cell antigen polypeptide and nucleic acid and preparation method and application thereof |
| 06/05/2013 | CN102293736B Preparation process of taxol-polymer medicine-carrying micelles |
| 06/05/2013 | CN102250047B Preparation method of taxol compound |
| 06/05/2013 | CN102232932B Pectin-adriamycin coniuncate lyophilized preparation, and preparation method thereof |
| 06/05/2013 | CN102212112B MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof |
| 06/05/2013 | CN102174550B Recombinant ubiquitin ligase PTB-U-box fusion gene and expression vector and application thereof |
| 06/05/2013 | CN102172349B Kit for treating small cell lung cancer and package thereof |
| 06/05/2013 | CN102151243B Paclitaxel injection and preparation method thereof |
| 06/05/2013 | CN102138991B Pharmaceutical composition for treating oral cancer and skin cancer |
| 06/05/2013 | CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof |
| 06/05/2013 | CN102127120B Antitumor platinum(II) complex and use thereof in preparation of antitumor medicine |
| 06/05/2013 | CN102049038B Application of gelatinase A inhibitory polypeptide modifier |
| 06/05/2013 | CN101991612B Preparation method of haematococcus pluvialis extracts |
| 06/05/2013 | CN101978990B Schisandra extract and preparation method and application thereof |
| 06/05/2013 | CN101977619B Soluble complexes of curcumin |
| 06/05/2013 | CN101967168B Triterpenoid saponin derivative and preparation method and application thereof |
| 06/05/2013 | CN101955442B Benzoyl fluorobenzene salicylamide compound and application thereof |
| 06/05/2013 | CN101954077B Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 06/05/2013 | CN101939326B Method for producing cycloplatinized platinum complexes, platinum complexes produced by said method, and the use thereof |
| 06/05/2013 | CN101921733B Preparation method and application of Qbeta-2aa phage virus-like particle protein |
| 06/05/2013 | CN101918373B Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 06/05/2013 | CN101906104B 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/05/2013 | CN101903028B Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer |
| 06/05/2013 | CN101899043B Tylophora ovata base analogs with anti-tumor activity and preparation method and use thereof |
| 06/05/2013 | CN101863984B Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane |
| 06/05/2013 | CN101845060B Beta-carboline ruthenium compound as well as preparation method and application thereof |
| 06/05/2013 | CN101809162B Anti-glypican-3 antibody having improved kinetics in plasma |
| 06/05/2013 | CN101805246B Urushiol compound and medicinal composition thereof, preparation method and application thereof |
| 06/05/2013 | CN101754978B Antigen associated with lung cancer and lymphoma |
| 06/05/2013 | CN101700995B Polyvinylarene substituted beta-diketones with anti-tumor effects |
| 06/05/2013 | CN101679340B Antitumoral dihydropyran-2-one compounds |
| 06/05/2013 | CN101675924B Application of ascaridol in preparing medicine for preventing helicobacter pylori and treating disease caused by helicobacter pylori |
| 06/05/2013 | CN101654672B RNA interference mediating small RNA molecules |
| 06/05/2013 | CN101654416B N-[3-nitro-4-methyl-phenyl]-4-aldehyde group-benzamide and preparation method thereof as well as preparation method of derivatives thereof |
| 06/05/2013 | CN101654401B Asymmetrical biphenyl compounds, medicinal compositions containing same and application of medicinal compositions |
| 06/05/2013 | CN101624325B Extracting agent for separating beta-elemene, extracting method and extracting device thereof |
| 06/05/2013 | CN101619043B Quinazoline derivant and medical application thereof |
| 06/05/2013 | CN101597280B Compound used as seven-pass transmembrane protein and based on sag structure |
| 06/05/2013 | CN101583601B Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 06/05/2013 | CN101563351B Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 06/05/2013 | CN101553473B Substituted pyrazoles, compositions containing these, method of production and use |
| 06/05/2013 | CN101535289B Novel phenylacetic acid derivative |
| 06/05/2013 | CN101522186B Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 06/05/2013 | CN101516891B Dihydrothieno pyrimidines as AKT protein kinase inhibitors |
| 06/05/2013 | CN101353655B siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof |
| 06/05/2013 | CN101326197B Human monoclonal antibodies to O8E |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/05/2013 | CN101108840B Chirality anona squamosa L. lactone compound with conformation limitation structure and synthesizing method and use thereof |
| 06/04/2013 | US8455625 Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12 |
| 06/04/2013 | US8455539 CCI-779 concentrate formulations |
| 06/04/2013 | US8455536 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 06/04/2013 | US8455510 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455489 Substituted pyrimidine compositions and methods of use |
| 06/04/2013 | CA2615738C Bifunctional protein anchors |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2542419C Use of glutamyl cyclase inhibitors in the treatment of familial british dementia and familial danish dementia |
| 06/04/2013 | CA2541709C Anti-pecam therapy for metastasis suppression |
| 06/04/2013 | CA2439178C Template-fixed peptidomimetics with antimicrobial activity |
| 06/04/2013 | CA2325735C Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation |